The induction of bone formation in rat calvarial defects and subcutaneous tissues by recombinant human BMP-2, produced in Escherichia coli

Ji Hyun Lee, Chang Sung Kim, Kyung Hee Choi, Ui Won Jung, Jeong Ho Yun, Seong Ho Choi, Kyoo Sung Cho

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

We investigated the ability of recombinant human bone morphogenetic protein-2, produced from Escherichia coli (ErhBMP-2), to form orthotopic and ectopic bone in rat models. BMP-2 was expressed in E. coli and extracted from the inclusion bodies. Critical-sized calvarial defects and subcutaneous pouches were created in rats, and an absorbable collagen sponge (ACS) was loaded with different doses of ErhBMP-2 for implantation. ACS alone and sham surgery controls were also included. Implant sites were evaluated by histological and/or histometric analyses following a 2- or 8-week healing interval. In the calvarial defect model, enhanced bone formation was observed with all doses of ErhBMP-2, while only limited amounts of new bone were found in controls. In the ectopic subcutaneous implant model, bone formation was clearly observed in all animals treated with ErhBMP-2 at 2 weeks. However, at 8 weeks, less new bone formation was detected than at 2 weeks. Nevertheless, the remaining new bone showed an advanced degree of bone remodeling and more maturity than that observed at 2 weeks. These results showed that ErhBMP-2 was osteoinductive under controlled in vivo conditions. Thus, ErhBMP-2 has definite potential as an alternative to rhBMP-2 produced in a eukaryotic system for clinical use.

Original languageEnglish
Pages (from-to)3512-3519
Number of pages8
JournalBiomaterials
Volume31
Issue number13
DOIs
Publication statusPublished - 2010 May 1

Fingerprint

Subcutaneous Tissue
Osteogenesis
Escherichia coli
Rats
Bone
Porifera
Tissue
Bone and Bones
Defects
Collagen
Bone Remodeling
Inclusion Bodies
Surgery
Animals
Proteins

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

@article{1dc43b7008ea4fa1b707a210421e1918,
title = "The induction of bone formation in rat calvarial defects and subcutaneous tissues by recombinant human BMP-2, produced in Escherichia coli",
abstract = "We investigated the ability of recombinant human bone morphogenetic protein-2, produced from Escherichia coli (ErhBMP-2), to form orthotopic and ectopic bone in rat models. BMP-2 was expressed in E. coli and extracted from the inclusion bodies. Critical-sized calvarial defects and subcutaneous pouches were created in rats, and an absorbable collagen sponge (ACS) was loaded with different doses of ErhBMP-2 for implantation. ACS alone and sham surgery controls were also included. Implant sites were evaluated by histological and/or histometric analyses following a 2- or 8-week healing interval. In the calvarial defect model, enhanced bone formation was observed with all doses of ErhBMP-2, while only limited amounts of new bone were found in controls. In the ectopic subcutaneous implant model, bone formation was clearly observed in all animals treated with ErhBMP-2 at 2 weeks. However, at 8 weeks, less new bone formation was detected than at 2 weeks. Nevertheless, the remaining new bone showed an advanced degree of bone remodeling and more maturity than that observed at 2 weeks. These results showed that ErhBMP-2 was osteoinductive under controlled in vivo conditions. Thus, ErhBMP-2 has definite potential as an alternative to rhBMP-2 produced in a eukaryotic system for clinical use.",
author = "Lee, {Ji Hyun} and Kim, {Chang Sung} and Choi, {Kyung Hee} and Jung, {Ui Won} and Yun, {Jeong Ho} and Choi, {Seong Ho} and Cho, {Kyoo Sung}",
year = "2010",
month = "5",
day = "1",
doi = "10.1016/j.biomaterials.2010.01.075",
language = "English",
volume = "31",
pages = "3512--3519",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "13",

}

The induction of bone formation in rat calvarial defects and subcutaneous tissues by recombinant human BMP-2, produced in Escherichia coli. / Lee, Ji Hyun; Kim, Chang Sung; Choi, Kyung Hee; Jung, Ui Won; Yun, Jeong Ho; Choi, Seong Ho; Cho, Kyoo Sung.

In: Biomaterials, Vol. 31, No. 13, 01.05.2010, p. 3512-3519.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The induction of bone formation in rat calvarial defects and subcutaneous tissues by recombinant human BMP-2, produced in Escherichia coli

AU - Lee, Ji Hyun

AU - Kim, Chang Sung

AU - Choi, Kyung Hee

AU - Jung, Ui Won

AU - Yun, Jeong Ho

AU - Choi, Seong Ho

AU - Cho, Kyoo Sung

PY - 2010/5/1

Y1 - 2010/5/1

N2 - We investigated the ability of recombinant human bone morphogenetic protein-2, produced from Escherichia coli (ErhBMP-2), to form orthotopic and ectopic bone in rat models. BMP-2 was expressed in E. coli and extracted from the inclusion bodies. Critical-sized calvarial defects and subcutaneous pouches were created in rats, and an absorbable collagen sponge (ACS) was loaded with different doses of ErhBMP-2 for implantation. ACS alone and sham surgery controls were also included. Implant sites were evaluated by histological and/or histometric analyses following a 2- or 8-week healing interval. In the calvarial defect model, enhanced bone formation was observed with all doses of ErhBMP-2, while only limited amounts of new bone were found in controls. In the ectopic subcutaneous implant model, bone formation was clearly observed in all animals treated with ErhBMP-2 at 2 weeks. However, at 8 weeks, less new bone formation was detected than at 2 weeks. Nevertheless, the remaining new bone showed an advanced degree of bone remodeling and more maturity than that observed at 2 weeks. These results showed that ErhBMP-2 was osteoinductive under controlled in vivo conditions. Thus, ErhBMP-2 has definite potential as an alternative to rhBMP-2 produced in a eukaryotic system for clinical use.

AB - We investigated the ability of recombinant human bone morphogenetic protein-2, produced from Escherichia coli (ErhBMP-2), to form orthotopic and ectopic bone in rat models. BMP-2 was expressed in E. coli and extracted from the inclusion bodies. Critical-sized calvarial defects and subcutaneous pouches were created in rats, and an absorbable collagen sponge (ACS) was loaded with different doses of ErhBMP-2 for implantation. ACS alone and sham surgery controls were also included. Implant sites were evaluated by histological and/or histometric analyses following a 2- or 8-week healing interval. In the calvarial defect model, enhanced bone formation was observed with all doses of ErhBMP-2, while only limited amounts of new bone were found in controls. In the ectopic subcutaneous implant model, bone formation was clearly observed in all animals treated with ErhBMP-2 at 2 weeks. However, at 8 weeks, less new bone formation was detected than at 2 weeks. Nevertheless, the remaining new bone showed an advanced degree of bone remodeling and more maturity than that observed at 2 weeks. These results showed that ErhBMP-2 was osteoinductive under controlled in vivo conditions. Thus, ErhBMP-2 has definite potential as an alternative to rhBMP-2 produced in a eukaryotic system for clinical use.

UR - http://www.scopus.com/inward/record.url?scp=77249145300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77249145300&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2010.01.075

DO - 10.1016/j.biomaterials.2010.01.075

M3 - Article

C2 - 20149447

AN - SCOPUS:77249145300

VL - 31

SP - 3512

EP - 3519

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 13

ER -